Icon Writers
Icon Group congratulates Chief Medical Officer, UK, Dr Penny Kechagioglou, on her appointment to the Board of Directors at RTsafe, a global medical technology company specialising in advanced radiotherapy quality assurance.
Icon Group congratulates Chief Medical Officer, UK, Dr Penny Kechagioglou, on her appointment to the Board of Directors at RTsafe, a global medical technology company specialising in advanced radiotherapy quality assurance.
Her appointment further strengthens the collaboration between Icon Group and RTsafe, building on an established partnership focused on advancing the safety and precision of radiotherapy.
In 2025, Icon Group adopted RTsafe’s first-to-market PRIME technology across Australia to enhance quality assurance and support the safe delivery of complex radiosurgery treatments.
Dr Kechagioglou said the appointment reflects a shared commitment to the future of cancer care.
“RTsafe’s mission is closely aligned with what I believe is essential in modern cancer care: safety, precision, innovation, and a deep commitment to patients and clinical teams,” said Dr Kechagioglou.
“I look forward to contributing my experience in oncology, healthcare leadership, and service transformation to support RTsafe’s continued growth and its impact in radiation oncology worldwide.”
Icon continues to work in partnership with RTsafe to support clinicians with confidence in delivering advanced treatments, reinforcing our commitment to improving patient outcomes through innovation and global collaboration.
